WHO 79th World Health Assembly Day 5: Member States Advance AI Pharmacovigilance Resolution and Digital Health Governance Framework

On Day 5 of the 79th World Health Assembly (WHA79) in Geneva (May 22, 2026), member states advanced a resolution on strengthening pharmacovigilance and medicines regulation through AI and real-world data — formalizing the use of AI for drug safety monitoring across global health systems. The International Federation of Pharmaceutical Manufacturers Associations (IFPMA) simultaneously published a formal position statement calling for harmonization of regulatory approaches, governance standards, and data frameworks for digital health and AI across the pharmaceutical sector. Vital Strategies simultaneously launched its 'PILLARs' initiative for AI-ready public health infrastructure in lower-income countries. The pharmacovigilance resolution marks a shift from voluntary AI adoption toward binding international commitments: 194 WHO member states formally advancing toward harmonized AI governance frameworks for drug safety surveillance across diverse health system contexts.